Mahon Paul A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Dec 12, 2025
- Accession no.
- 0001231589-25-000012
- Filed
- Dec 12, 2025
- Trade date
- Dec 11, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.33M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mahon Paul ACIK 0001231589 | Officer (EVP & GENERAL COUNSEL) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | Common Stock | MOption exerciseAcquired | +11,000 | $146.03 | +$1,606,330 | 47,781 | Direct | |
| Dec 11, 2025 | Common Stock | SSaleDisposed | −560 | $482.22F2 | −$270,043.2 | 47,221 | Direct | |
| Dec 11, 2025 | Common Stock | SSaleDisposed | −900 | $483.25F3 | −$434,925 | 46,321 | Direct | |
| Dec 11, 2025 | Common Stock | SSaleDisposed | −5,220 | $484.31F4 | −$2,528,098.2 | 41,101 | Direct | |
| Dec 11, 2025 | Common Stock | SSaleDisposed | −2,804 | $485.22F5 | −$1,360,556.88 | 38,297 | Direct | |
| Dec 11, 2025 | Common Stock | SSaleDisposed | −1,116 | $486.36F6 | −$542,777.76 | 37,181 | Direct | |
| Dec 11, 2025 | Common Stock | SSaleDisposed | −400 | $487.37F7 | −$194,948 | 36,781 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | Common Stock | MOption exerciseDisposed | −11,000 | $0.00 | $0 | 20,250 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $481.84 to $482.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $482.88 to $483.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $483.88 to $484.82. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $484.88 to $485.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $485.90 to $486.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $487.24 to $487.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.